Drug Profile
Research programme: glycoprotein based therapeutics - GlycoForm
Alternative Names: GLY 510; GLY 511; GLY 515nLatest Information Update: 27 Jun 2012
Price :
$50
*
At a glance
- Originator GlycoForm
- Developer Aston University; Cerebricon; GlycoForm (CEASED); PolyTherics
- Class Glycoproteins; Peptide fragments
- Mechanism of Action Erythropoiesis stimulants; Glycosylation stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anaemia; Gaucher's disease; Stroke
Most Recent Events
- 31 Dec 2011 Discontinued - Preclinical for Stroke in Finland (IV)
- 31 Dec 2011 Discontinued for Anaemia in United Kingdom (IV)
- 31 Dec 2011 Discontinued for Anaemia in United Kingdom (SC)